Letters to the Editor
Trimethoprim-Sulfamethoxazole–Induced Methemoglobinemia in an HIV-Infected Patient

https://doi.org/10.4065/79.6.829-aGet rights and content

REFERENCES (10)

  • EC Gordon-Smith

    Drug-induced oxidative haemolysis

    Clin Haematol

    (1980)
  • RH Girdwood

    Effects of drugs and their metabolites on blood and blood forming organs

  • JA Damergis et al.

    Methemoglobinemia after sulfamethoxazole and trimethoprim [letter]

    JAMA

    (1983)
  • A Lopez et al.

    Methaemoglobinaemia secondary to treatment with trimethoprim and sulphamethoxazole associated with inhaled nitric oxide [letter]

    Acta Paediatr

    (1999)
  • B Jakobson et al.

    Methemoglobinemia associated with a prilocaine-lidocaine cream and trimethoprim-sulphamethoxazole: a case report

    Acta Anaesthesiol Scand

    (1985)
There are more references available in the full text version of this article.

Cited by (13)

  • 26 Miscellaneous antibacterial drugs

    2007, Side Effects of Drugs Annual
    Citation Excerpt :

    Older sulfonamides were associated with methemoglobinemia, but this is rare with co-trimoxazole. A 66-year-old African American man with advanced HIV infection developed methemoglobinemia while receiving intravenous co-trimoxazole (300 mg of trimethoprim + 1500 mg of sulfamethoxazole) every 6 hours (171A). Quantitative stool cultures in two patients receiving co-trimoxazole for 2 years showed a substantially suppressed Gram-negative aerobic flora, while Enterococcus species and anaerobes were not affected; yeasts were moderately increased (172A).

  • 28 Antiprotozoal drugs

    2007, Side Effects of Drugs Annual
  • Considerations when prescribing trimethoprim-sulfamethoxazole

    2011, CMAJ. Canadian Medical Association Journal
    Citation Excerpt :

    In general, neurologic symptoms occur within days of continuous treatment and resolve following discontinuation of trimethoprim–sulfamethoxazole. Several case reports describe methemoglobinemia in patients taking trimethoprim–sulfamethoxazole.7,8 Although this adverse effect is rare, the sulfamethoxazole component can induce methemoglobinemia, which occurs when more than 1% of heme iron exists in the ferric (Fe3+) redox state, rather than the usual ferrous (Fe2+) state.

View all citing articles on Scopus
View full text